Company: SMNR
Filing Date: 2025-08-12
Form Type: S-4/A
Source: 0001193125-25-178821
Chunk: 449

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-12
Form: S-4/A
Chunk 449
---
 Regulations and administrative guidance, withholding under FATCA generally applies to payments of dividends. While withholding under FATCA generally would also apply to payments of gross proceeds from the sale or other disposition of securities (including New Semnur Common Stock), proposed Treasury Regulations eliminate FATCA withholding on payments of gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury Regulations until final Treasury Regulations are issued. All holders should consult their tax advisors regarding the possible implications of FATCA on their investment in Domesticated Denali securities.

<div align='center'>268</div>

SELECTED HISTORICAL FINANCIAL DATA OF DENALI The following selected consolidated statements of operations data for the year ended December 31, 2024 and 2023 and balance sheet data as of December 31, 2024 and 2023 have been derived from Denali’s audited consolidated financial statements included elsewhere in this proxy statement/prospectus. The following selected consolidated statements of operations data for the three months ended March 31, 2025 and 2024 and the selected consolidated balance sheet data as of March 31, 2025 have been derived from Denali’s unaudited consolidated financial statements included elsewhere in this proxy statement/prospectus. Denali’s unaudited consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments and accruals, necessary for a fair statement of the information for the interim periods. The historical results presented below are not necessarily indicative of the results to be expected for any future period. You should read the selected financial data presented below in conjunction with the section of this proxy statement/prospectus titled “ Management’s Discussion and Analysis of Financial Condition and Results of Operations of Denali” and Denali’s audited and unaudited consolidated financial statements and the related notes included elsewhere in this proxy statement/prospectus.

|                                                                               | Consolidated Statements of Operations Data: |            |  For the Three 
   Months Ended 
 March 31, 2025 |   |     |            |  For the Three 
   Months Ended 
 March 31, 2024 |   |     |   |      For the Year 
             Ended 
 December 31, 2024 |   |     |   |      For the Year 
             Ended 
 December 31, 2023 |   |
|:------------------------------------------------------------------------------|:--------------------------------------------|:-----------|---------------:|:--|